Iveric Bio Inc expected to post a loss of 25  cents a share - Earnings Preview

IVERIC bio

22/02/2022 14:54

* Iveric Bio Inc  ISEE.OQ   ISEE.O  is expected to show no
change
in quarterly revenue when it reports  results on February 24. 
    * ​Refinitiv's mean analyst estimate for Iveric Bio Inc is
for a
loss of 25 cents per share. For the same quarter last year, the
company reported a loss of 27 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Iveric Bio
Inc is
$25​, about 41.6% above​ its last closing price of $14.60. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.29       -0.29      -0.23     Beat    20.1
 Jun. 30 2021  -0.26       -0.26      -0.32     Missed  -22.8
 Mar. 31 2021  -0.25       -0.25      -0.29     Missed  -16.5​
 Dec. 31 2020              -0.26      -0.27     Missed  -5.5
 ​​Sep.        -0.22       -0.22      -0.27     Missed  -23.6
 30 2020                                                
 Jun. 30 2020  -0.31       -0.31      -0.32     Missed  -3.2​
 Mar. 31 2020  -0.39       -0.39      -0.28     Beat    28.2
 Dec. 31 2019  -0.28       -0.28      -0.39     Missed  -39.3
 This summary was machine generated February 22 at 14:54 GMT. 
All figures in US dollars  unless otherwise stated